Company Monitoring Page for Roche

latest headlines for company on cafepharma

ImmunoGen Is Living Life in the Fast Lane
Motley Fool
Thu, 11/8/12 - 12:07 pm
Tags:
Immunogen, Roche, T-DM1, breast cancer
New Drugs for Lipids Set Off Race
NY Times, NY
Tue, 11/6/12 - 12:07 pm
Tags:
PCSK9 inhibitors, Sanofi, Regeneron, Amgen, Pfizer, Roche
Roche’s Good Cholesterol Drug Shows Negative Side Effects
Bloomberg
Mon, 11/5/12 - 04:59 pm
Tags:
Roche, dalcetrapib, CETP inhibitors
India Revokes Patent On Roche Hepatitis C Drug
Pharmalot
Mon, 11/5/12 - 11:22 am
Tags:
India, patents, Roche, hepatitis C, Pegasys
BMJ editor flogs Roche for Tamiflu data secrecy
Fierce Pharma
Wed, 10/31/12 - 11:15 am
Tags:
Roche, clinical trials, Tamiflu, British Medical Journal
Survey: Many docs will be slow to switch to biosimilar mAbs
Fierce Biotech
Mon, 10/29/12 - 11:42 am
Tags:
oncologists, mAbs, biosimilars, Roche, MabThera
New Developments In Lipids To Watch Closely
Seeking Alpha
Sun, 10/28/12 - 11:31 am
Tags:
Lpath, Pfizer, iSONEP, Asonept, macular degeneration, multiple sclerosis, MS, Regeneron, Roche, Bayer, Sanofi, Valeant Pharmaceuticals, GSK
Roche Diagnostics cutting 100 jobs in diabetes restructuring
FierceMedicalDevice
Tue, 10/23/12 - 11:04 pm
Tags:
Roche, diabetes, job cuts
Roche continues to restructure diabetes unit
Indianapolis Business Journal, IN
Tue, 10/23/12 - 09:17 am
Tags:
Roche, restructuring, diabetes, layoffs
Swiss drugmaker Roche posts strong rise in sales thanks to cancer-fighting products
Yahoo/AP
Tue, 10/16/12 - 11:53 am
Tags:
Roche
Roche Still Seeks Sequencing Expansion After Illumina
Bloomberg
Tue, 10/16/12 - 10:48 am
Tags:
Roche, Illumina, gene sequencing
Another Prospective Alzheimer's Trial
Seeking Alpha
Sat, 10/13/12 - 12:23 pm
Tags:
solanezumab, Eli Lilly, LY2886721, gantenerumab, Roche
Is Alzheimer's Research the Next Big Thing in Biotech?
Motley Fool
Thu, 10/11/12 - 10:47 am
Tags:
Alzheimer's disease, Eisai, Forest Labs, JNJ, Pfizer, Eli Lilly, Roche
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:39 am
Tags:
vortioxetine, Vectura, tofacitinib, Takeda, T-DM1, Sanofi, Roche, REGN727, Regeneron, Reata, QVA149, Pfizer, Odanacatib, Novartis, MorphoSys, Merck, macitentan, Lundbeck, Immunogen, GSK, GS-7977, Gilead, gantenerumab, Eliquis, darapladib, Bristol-Myers Squibb, Biogen Idec, BG-12, Bayer, Bardoxolone, Anacetrapib, Alpharadin, Algeta, Actelion, AbbVie
Roche teams up with VC in hearing loss project
Pharma Times, UK
Thu, 10/11/12 - 09:32 am
Tags:
Roche, hearing loss, venture capital
Lilly, Roche Drugs Chosen for Alzheimer Prevention Trial
Bloomberg
Wed, 10/10/12 - 11:32 am
Tags:
Roche, Alzheimer's disease, Eli Lilly, solanezumab, gantenerumab
Roche Faces New Foe as Boehringer Plans a Rituxan Copy
Bloomberg
Fri, 10/5/12 - 11:27 am
Tags:
Roche, Rituxan, Boehringer Ingelheim, rheumatoid arthritis
Celgene's Pipeline Offers Catalysts Into 2013
Seeking Alpha
Thu, 10/4/12 - 10:43 am
Tags:
Celgene, JNJ, Bristol-Myers Squibb, Roche, ONYX Pharmaceuticals, Abraxane, Eli Lilly
Exelixis: First Partnered Program Enters Phase III
Seeking Alpha
Wed, 10/3/12 - 11:20 am
Tags:
Exelixis, Roche, GSK, GDC-0973, MEK inhibitor, melanoma
Roche declines comment on report of Illumina bid, Bloomberg reports
Yahoo/Fly on the Wall
Tue, 10/2/12 - 11:57 am
Tags:
Roche, Illumina, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.